FDA Inspection 1225117 — S.A.E.G.
The FDA completed an inspection of S.A.E.G. on December 5, 2023 in Owingsville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 5, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Owingsville, KY (United States)